JPMorgan raises UCB SA stock outlook, doubles price target By Investing.com
JPMorgan raises UCB SA stock outlook, doubles price target…
188,250€
0,94%
Echtzeit-Aktienkurs UCB S.A.
Bid:
Ask:
Nachrichten zur UCB S.A. Aktie
ANALYSE-FLASH: JPMorgan hebt UCB auf 'Neutral' - Ziel deutlich hoch auf 150 Euro
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für die Aktien von UCB…
UCB SA (UCBJF) Full Year 2023 Earnings Call Transcript
…
Global Axial Spondyloarthritis (axSpA) Market Report 2023
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been…
Active Pharmaceutical Ingredients (API) Market Size to Surpass USD 349.2 Billion Growth by 2030, Exhibit a CAGR of 6.5%
[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…
ClearPoint Neuro und UCB unterzeichnen Lizenzvereinbarung für die Verabreichung von Gentherapeutika
SOLANA BEACH, Kalifornien, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), ein weltweit tätiges Unternehmen,…
Veeva in pact with Belgian biopharma UCB for tech-driven clinical trials
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Govt starts inquiry into Google app payments antitrust compliance
The Competition Commission of India (CCI) has initiated an inquiry into Google after receiving allegations from Match Group and Indian…
XFRA : DIVIDEND/INTEREST INFORMATION - 28.04.2023 - BE0003739530
Das Instrument UNC BE0003739530 UCB S.A. EQUITY wird cum Dividende/Zinsen gehandelt am 27.04.2023 und ex Dividende/Zinsen am 28.04.2023
The instrument UNC…
UCB Convening Notice to the General Meeting of theShareholders 2023
The Board of Directors invites the shareholders for the general meeting of shareholders (the “General Meeting”) which will be held…
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been…
Praxis Precision Medicines and UCB collaborate for epilepsy research
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and…
UCB drug meets main goals of 2 phase 3 trials for painful skin disorder
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis
Two articles report results from the Phase 3 BE OPTIMAL and BE COMPLETE studies evaluating bimekizumab, an investigational, selective inhibitor…
Outlook on the Psoriatic Arthritis Treatment Global Market to 2027 - Players Include AbbVie, Johnson & Johnson, UCB, Amgen and Bristol-Myers Squibb
DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has…
UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care
21 scientific presentations, including 7 late breakers, showcase the breadth of UCBs portfolio, reinforcing commitment to improving the lives of…
Automotive Grade Linux Releases UCB 14 Platform with Additional Support for App Development with Flutter
SAN FRANCISCO, Nov. 18, 2022 /PRNewswire/ -- Automotive Grade Linux (AGL), a collaborative cross-industry effort developing an open source platform…
UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients
New drug application (NDA) for zilucoplan seeks approval for the treatment of generalized myasthenia gravis (gMG) in adult patients who…
UCB touts positive late-stage data for bimekizumab in several indications
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insights into the Rheumatoid Arthritis (RA) Online Space, 2022 Report Featuring UCB, Galapagos, BMS, Amgen, Pfizer, Sanofi, AbbVie, Genentech, Janssen, & Eli Lilly
DUBLIN, Oct. 26, 2022 /PRNewswire/ -- The "Rheumatoid Arthritis (RA) Therapy Area Report" report has been added to ResearchAndMarkets.coms offering.…
Stem Cell UCB Market Size to Grow by USD 1.47 Bn, North America to be Largest Contributor to Market Growth - Technavio
NEW YORK, Oct. 9, 2022 /PRNewswire/ -- The stem cell umbilical cord blood (UCB) market has been segmented by end-user…